Skip to main content
Jenkem Technology Co., Ltd. logo

Jenkem Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688356 ISIN · CNE1000043K9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 569 across all filing types
Latest filing 2024-11-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688356

About Jenkem Technology Co., Ltd.

https://www.jenkem.com/

Jenkem Technology Co., Ltd. specializes in the research, development, and large-scale manufacturing of high-purity polyethylene glycol (PEG) derivatives and related polymers. The company provides a comprehensive portfolio of PEG products, including monodisperse and polydisperse PEG linkers, multi-arm PEGs, and functionalized derivatives such as NHS esters, maleimides, and amines. These materials are primarily utilized in advanced drug delivery systems, PEGylation of proteins and peptides, and the development of medical devices and hydrogels. In addition to its core PEG offerings, the company produces biodegradable polymers, including PLA, PLGA, and PCL. Jenkem Technology supports the global biotechnology and pharmaceutical sectors through custom synthesis and high-quality manufacturing processes designed to meet rigorous technical specifications for therapeutic and diagnostic applications.

Recent filings

Filing Released Lang Actions
关于2021年限制性股票激励计划预留授予部分第二个归属期归属结果暨股份上市公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Jiankai Technology Co., Ltd. regarding the listing of shares related to the 2021 restricted stock incentive plan's reserved grant portion for the second vesting period. It details the decision-making process, the number of shares vested, the listing date, and the impact on share capital and earnings per share. The document includes references to board meetings, shareholder meetings, and regulatory filings but does not contain comprehensive financial statements or detailed financial performance data. The document length is 4291 characters, which is relatively short and primarily serves as an official announcement of the stock listing and related corporate actions rather than a full report. Therefore, it fits best as a Regulatory Filing (RNS) rather than a full Annual Report, Interim Report, or Remuneration Information. It is not a proxy solicitation, dividend notice, or capital change announcement in the strict sense but a regulatory announcement about stock incentive plan share listing and registration.
2024-11-13 Chinese
关于自愿披露聚乙二醇伊立替康用于治疗伴脑转移的三阴性乳腺癌II期临床试验完成首例受试者入组的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Beijing Jiankai Technology Co., Ltd. about the completion of the first patient enrollment in a Phase II clinical trial for a drug candidate. It details the clinical trial progress, drug development status, and risk warnings. The document is short (1178 characters) and does not contain financial data, earnings, or regulatory certifications. It is an announcement of a clinical trial milestone rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The content is a project progress announcement related to clinical trials, which is best categorized under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-11-12 Chinese
第三届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting, including approval of changing the company's 2024 audit firm and the proposal to convene a 2024 second extraordinary shareholders meeting. It references other announcements for details but itself is a board meeting resolution announcement. There is no financial data or report content, nor is it a voting result or proxy solicitation. The document fits best under Board/Management Information (MANG) as it concerns board decisions and governance matters.
2024-11-08 Chinese
第三届监事会第九次会议决议公告
Audit Report / Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Jiankai Technology Co., Ltd. regarding the change of the company's 2024 audit firm. It details the meeting date, attendance, and voting results on the proposal to appoint Deloitte Huayong as the auditor for the 2024 financial and internal control audit. The document does not contain any financial statements or detailed audit reports but is an official announcement of a board decision related to audit matters. This fits best under 'Audit Report / Information (AR)' as it relates to audit institution appointment and audit-related decisions, but it is not a full audit report or annual report. The document is not a report publication announcement since it contains substantive meeting and decision information, nor is it a regulatory filing or other category. Therefore, the classification is AR with high confidence. FY 2024
2024-11-08 Chinese
关于召开2024年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2024 second extraordinary general meeting of shareholders for Beijing Jienkai Technology Co., Ltd. It details the meeting date, voting methods, agenda items, and procedural instructions for shareholders. It does not contain financial statements or detailed financial analysis but is an announcement related to a shareholder meeting. The document specifically mentions the agenda includes a proposal about changing the company's 2024 audit institution, but this is part of the meeting agenda, not the audit report itself. The document length is 2723 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-11-08 Chinese
关于变更公司2024年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the company's audit firm for the fiscal year 2024. It details the new auditor's qualifications, the reasons for the change, communication with the previous auditor, and the approval process by the audit committee and board of directors. It does not contain any financial statements or audit reports themselves but rather informs stakeholders about the auditor change. The document length is 3215 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits the category of an Audit Report / Information announcement about auditor change rather than the audit report itself. FY 2024
2024-11-08 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.